Ignite Creation Date:
2024-05-05 @ 4:50 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00326911
Status:
TERMINATED
Last Update Posted:
2011-05-25
First Post:
2006-05-15
Brief Title:
Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer
Sponsor:
Organization:
Eli Lilly and Company